Peptide record

TPDB43123

ACE inhibitor Anticancer Antihypertensive standard
11 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB43123
ACE inhibitor
Anticancer Antihypertensive
Cardiometabolic peptides Cancer-related peptides
Peptipedia AHTPDB AHTpin
standard
No
A 11-aa standard natural multi-activity (Anticancer and Antihypertensive) peptide sequence curated from Peptipedia, AHTPDB, and AHTpin, with an available 3D structural model.
Sequence
VENLHLPLPLL
Physicochemical Analysis
C60H100N14O15
ARDCQGIKMFSTWY
L
1257.54
5.13
1
1
6
-1
1.57
0.891
203.64
Mammalian: 100 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
1
Residue Composition
number
0
A
0
R
1
N
0
D
0
C
1
E
0
Q
0
G
1
H
0
I
5
L
0
K
0
M
0
F
2
P
0
S
0
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 0 R: 0 N: 1 D: 0 C: 0 E: 1 Q: 0 G: 0 H: 1 I: 0 L: 5 K: 0 M: 0 F: 0 P: 2 S: 0 T: 0 W: 0 Y: 0 V: 1
Chemical Descriptors
11
C60H100N14O15
1257.54
5.13
-1
1.57
0.891
1257.5168
1256.7469
Evidence Records 1 records
Evidence 1 Activity

Activity

IC50
Antihypertensive
175.00 µM
Inhibitor of Angiotensin-converting enzyme (EC 3.4.15.1) (MEROPS ID: M02-001)
ACE inhibitor
ah

Source & Reference

AHTPDB
Robert M. C., Razaname A., Mutter M., Juillerat M. A.
Identification of angiotensin-I-converting enzyme inhibitory peptides derived from sodium caseinate hydrolysates produced by Lactobacillus helveticus NCC 2765. J. Agric. Food. Chem., 52, 6923-6931, 2004
2004
Journal

Other

Source Activity Label Source Definition
Antihypertensive
AHTPDB manually curated experimentally validated antihypertensive peptide annotation.
11
BIOPEP-UWM database of bioactive peptides SMILES: N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@H](CC1=CN=C[NH]1)C(=O)N[C@@]([H])(CC(C)C)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(CC(C)C)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(CC(C)C)C(=O)O InChI=1S/C60H100N14O15/c1-30(2)21-38(66-54(82)41(27-47(61)75)68-50(78)37(17-18-48(76)77)65-57(85)49(62)35(11)12)51(79)67-40(26-36-28-63-29-64-36)53(81)70-42(23-32(5)6)58(86)74-20-14-16-46(74)56(84)71-43(24-33(7)8)59(87)73-19-13-15-45(73)55(83)69-39(22-31(3)4)52(80)72-44(60(88)89)25-34(9)10/h28-35,37-46,49H,13-27,62H2,1-12H3,(H2,61,75)(H,63,64)(H,65,85)(H,66,82)(H,67,79)(H,68,78)(H,69,83)(H,70,81)(H,71,84)(H,72,80)(H,76,77)(H,88,89)/t37-,38-,39-,40-,41-,42-,43-,44-,45-,46-,49-/m0/s1 InChIKey=DBHLZNQDTOOIDF-PTPXOIFGSA-N Anticancer peptide according to the BIOPEP-UWM database of bioactive peptides (ID 8317), the DFBP database
Additional Detail Fields 1 fields
11